Abstract
On May 18, 1980, Mt. Saint Helens erupted and showerred the state of Washington with volcanic ash. This ash contained 17–19% aluminum by weight (Anthony Irving, University of Washington, personal communication). In such circumstances, the question of the source of aluminum does not seem difficult. Eight percent of the earth’s crust is aluminum, making it the third most common element. However, most of this metal remains in the rocks or soil as insoluble aluminuo-silicates. With weathering, it may turn to aluminum hydroxide. The concentrations in ground water are usually between 10–1000 μg/l (0.5–37 μmol/l; one part per million = 1000 μg/l) In sea water aluminum is only 1 μg/l [1]. Acid rain can enhance aluminum mobilization; whereas the aluminum concentration in deep soil and springs are negligible in the forests of Washington, the concentrations increase to 602 μg/l (67 μEq/l) in New Hampshire where excess sulfuric acid is found in the rain. Such leaching is a modern phenomenon [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Hem JD, 1986: Geochemistry and aqueous chemistry of aluminum. Kidney Int 29 (Suppl. 18): S3.
Cronan CS, Schofield CL, 1979: Aluminum leaching response to acid precipitation: effects on high-elevation watersheds in the Northeast. Science 204: 304.
Alfrey AC, Hegg A, Craswell P, 1980: Metabolism and toxicity of aluminum in renal failure. Am J CLin Nutr 33: 1509.
Wills MS, Savory J, 1985: Water content of aluminum, dialysis dementia, and osteomalacia. Environmental Health Perspectives 63: 141.
McLaughlin AIG, Kazantzis G, King E, Teare D, Porter RJ, Owen R, 1962: Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminum dust. J Industr Med 19: 253.
Alfrey AC, Mishell JM, Burks J, et al., 1972: Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Amer Soc Artif Int Org 18: 257.
Alfrey AC, LeGendre GR, Kaehny WD, 1976: The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294: 184.
Platts MM, Goode GC, Hislop JS, 1977: Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J 2: 657.
Wing AJ, Brunner FP, Brynger H, et al., 1980: Dialysis dementia in Europe Lancet ii: 190.
Parkinson IS, Ward MK, Feest TG, Fawcett RWP, Kerr DNS, 1979: Fracturing dialysis osteodystrophy and dialysis encephalopathy. Lancet i: 406.
Dunea G, Mahurkar SD, Mamdani B, Smith EC, 1978: Role of aluminum in dialysis dementia. Ann Intern Med 88: 502.
Berkseth RO, Shapiro FL, 1980: An epidemic of dialysis encephalopathy and exposure to high aluminum dialysate. In Controversies in Nephrology, Vol II. Eds. GE Schreiner, JF Winchester, W Mattern, BF Mendelson. Georgetown University, Washington, D.C.
Rozas VV, Port FK, Rutt WM, 1978: Progressive dialysis encephalopathy from dialysate aluminum. Arch Intern Med 138: 1375.
Flendrig JA, Kruis H, Das HA, 1976: Aluminum and dialysis dementia. Lancet i: 1235.
Branger B, Ramperez P, Marigliano N, Mion H, Shaldon S, Mion C, 1980: Aluminum transfer in bicarbonate dialysis using a sorbent regenerative system: an in vitro study. Proc Eur Dial Trans Assoc 17: 213.
Gacek EM, Babb AL, Uvelli DA, Fry DL, Scribner BH, 1979: Dialysis dementia: the role of dialysate pH in altering the dialyability of aluminum. Trans Am Soc Artif Intern Organs 25: 409.
Ricanati ES, Ott SM, Klein KL, Alfrey AC, Sherrard DJ, Coburn JW, 1982: Evaluation of bone in dialysis patients exposed to aluminum in dialysate. Kidney Int 21: 176.
Platts MM, Owen G, Smith S, 1984: Water purification and the incidence of fractures in patients receiving home haemodialysis supervised by a single centre: evidence for safe upper limit of aluminum in water. Br Med J 288: 969.
Milliner DS, Nebeker HG, Ott SM, et al., 1984: Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. Ann Intern Med 101: 775.
Kovalchik MT, Kaehny WD, Hegg AP, Jackson JT, Alfrey AC, 1978: Aluminum kinetics during hemodialysis. J Lab Clin Med 92: 712.
Kaehny WD, Alfrey AC, Holman RE, Shorr WJ, 1977: Aluminum transfer during hemodialysis. Kidney Int 12: 361.
Hodge MC, Day JP, O’Hara M. Ackrill P, Ralston AJ, 1981: Critical concentrations of aluminum in water used for dialysis. Lancet ii: 802.
Graf H, Stummvoll HK, Meisinger V, Kovarik J, Wolf A, Pinggera W, 1981: Aluminum removal by hemodialysis. Kidney Int 19: 587.
Cannata JB, Briggs JD, Junor BJR, Fell GS, Beastall G. 1983. Effect of acute aluminum overload on calcium and parathyroid-hormone metabolism. Lancet i: 501.
Smith AJ, Faugere MC, Abreo K, Fanti P, Julian B, Malluche HH, 1986: Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis. Am J Nephrol 6: 275.
Cumming AD, Simpson G, Bell D, Cowie J, Winney RJ, 1982: Acute aluminum intoxication in patients on continuous ambulatory peritoneal dialysis. Lancet i: 103.
Klein GL, Targoff CM, Ament ME, et al., 1980: Bone disease associated with total parenteral nutrition. Lancet ii: 1041.
Ott SM, Maloney NA, Klein GL, et al., Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med 98: 910.
Klein GL, Alfrey AC, Miller NL, et al., 1982: Aluminum loading during total parenteral nutrition. Am J Clin Nutr 35: 1425.
Vargas J, Klein G, Ament M, et al., 1986: Parenteral nutrition-related bone disease improves after aluminum load is reduced. J Bone Mineral Res 1 (Suppl 1) #215.
deVernejoul MC, Messing B, Modrowski D, Bielakoff J, Buising A, Miravet L, 1985: Multifactorial low remodeling bone disease during cyclic total parenteral nutrition. J Clin Endocrinol Metab 60: 109.
Lipkin EW, Chait A, Ott S, Sherrard D, Chesnut C, 1985: The changing spectrem of bone disease in long-term parenteral nutrition. Clin Res 33: 71A.
Sedman AB, Klein GL, Merritt RJ, et al., 1985: Evidence of aluminum loading in infants receiving intravenous therapy, N Engl J Med 312: 1337.
Milliner DS, Shinaberger JH, Shuman P, Coburn JW, 1985: Inadvertent aluminum admin-istration during plasma exchange due to aluminum contamination of albumin-replacement solutions. N Engl J Med 312: 165.
Heyman MS, Klein GL, Wong A, et al., 1986: Aluminum does no accumulate in teenagers and adults on prolonged parenteral nutrition containing free amino acids. J Parenteral Enteral Nutrition 10: 86.
Koo WWK, Kaplan LA, Bendon R, et al., 1986: Response to aluminum in parenteral nutrition during infancy. J Pediatr 109: 877.
Gorsky JE, Dietz AA, Spencer H, Osis D, 1979: Metabolic balance of aluminum studied in six men. Clin Chem 25: 1739.
Recker RR, Blotcky AJ, Leffler JA, Rack EP, 1977: Evidence for aluminum absorption from the gastrointertinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J Lab Clin Med 90: 810.
Larson EA, Ash SR, White JL, Hem SL, 1986: Phosphate binding gels: balancing phosphate absorption and aluminum toxicity. Kidney Int 29: 1131.
Lione A, 1985: Aluminum intake from non-prescription drugs and sucralfate. Gen Pharmac 16: 223.
Sedman AB, Wilkening GN, Warady BA, Lum GM, Alfrey AC, 1984: Encephalopathy in childhood secondary to aluminum toxicity. J Pediatr 105: 836.
Kaye M. 1983. Oral aluminum toxicity in a non-dialyzed patient with renal failure. Clin Nephrol 20: 208.
Felsenfeld AJ, Gutman RA, Llach F, Harrelson JM, 1982: Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis. Am J Nephrol 2: 147.
Griswold WR, Raznik V, Mendoza SA, Traner D, Alfrey AC, 1983: Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide. Pediatr 71: 56.
Nathan E, Pedersen SE, 1980: Dialysis encephalopathy in a non-dialzsed uraemic boy treated with aluminum hydroxide orally. Acta Paediatr Scand 69: 793.
Andreoli SP, Bergstein JM, Sherrard DJ, 1984: Aluminum intoxication from aluminum- containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med 310: 1079.
Sedman AB, Miller NL, Warady BA, Lum GM, Alfrey AC, 1984: Aluminum loading in children with chronic renal failure. Kidney Int 26: 201.
McKinney TD, Basinger M, Sawson E, Jones MM, 1982: Serum aluminum levels in dialysis dementia. Nephron 32: 53.
Heaf JG, Podenphant J, Anderson JR, 1986: Bone aluminum deposition in maintenance dialysis patients treated with aluminum-free dialysate: role of aluminum hydroxide consumption. Neprhon 42: 210.
Cannata JB, Briggs JD, Junor BJR, Fell GS, 1983: Aluminum hydroxide intake: real risk of aluminum toxicity. Br Med J 286: 1937.
Ott SM, Maloney NA, Coburn JW, Alfrey AC, Sherrard DJ, 1982: The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 307: 709.
Kaehny WD, Hegg AP, Alfrey AC, 1977: Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med 296: 1389.
Greger JL, Baier MJ, 1983: Excretion and retention of low or moderate levels of aluminum by human subjects. Fd Chem Toxic 21: 473.
Cam JM, Luch VA, Eastwood JB, de Wardener HE, 1976: The effect of aluminum hydroxide orally on calcium, phosphorus, and aluminum metabolism in normal subjects. Clin Sei Molec Med 51: 407.
Knoll O, Kellinghaus H, Bertram HP, Zumkley H, Graefe U, 1984: Gastrointestinal absorption of aluminum in chronic renal insufficiency Contr Nephrol 38: 24.
Marsden ANE, Parkinson IS, Ward MK, Ellis HA, Kerr DNS, 1979: Evidence for aluminum accumulation in renal failure. Proc Eur Dial Trans Assoc 16: 588.
Biswas CK, Arze RS, Ramos JM, et al., 1982: Effect of aluminum hydroxide on serum ionised calcium, immunoireactive parathyroid hormone, and aluminum in chronic renal failure. Br Med J 284: 776–8.
Wallace MR, Pybus J, 1983: Plasma aluminum levels in patients on maintenance haemo- dialysis fall when oral aluminum hydroxide is withdrawn. New Zealand Med J 96: 793.
Moriniere PH, Roussel A, Tahiri Y, et al., 1982: Substitution of aluminum hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperaluminaemia and equal control of hyperparathyroidism. Proc Eur Dial Trans Assoc 19: 784.
Norris KC, Crooks PW, Nebeker HG, et al., 1985: Clinical and laboratory features of aluminum-related bone disease: difference between sporadic and ’epidemic’ forms of the syndrome. Am J Kidney Dis 6: 342.
Andress DL, Maloney NA, Endress DB, Sherrard DJ, 1986: Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. J Bone Mineral Res 1: 391.
Ihle BU, Becker GJ, 1985: Gastrointestinal absorption of aluminum. Am J Kidney Dis 6: 302.
Chan YL, Alfrey AC, Posen S, et al., 1983: Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology. Calcif Tissue Int 35: 344.
Salusky IB, Coburn JW, Paunier L, Sherrard DJ, Fine RN, 1984: Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis. J Pediatr 105: 717.
Andress DL, Kopp JB, Maloney NA, Coburn JW, Sherrard DJ, 1987: Early deposition of aluminum in bone in diabetic patients on hemodialysis. N Engl J Med 316: 292.
Cannata JB, Suarez C, Cuesta V, et al., 1984: Gastrointestinal aluminum absorption: Is it modulated by the iron-absorptive mechanism? Proc Eur Dial Trans Assoc 21: 354.
Slatopolsky E, 1987: The interaction of parathyroid hormone and aluminum in renal osteodystrophy. Kidney Int 31: 842.
Mayor GH, Sprague SM, Hourani MR, Sanchez TV, 1980: Parathyroid hormone mediated aluminum deposition and egress in the rat. Kidney Int 17: 40.
Andress DL, Ott SM, Maloney NA, Sherrard DJ, 1985: Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. N Engl J Med 312: 468.
Drueke T, Lacour B, Touam M, Basile C, Bourdon R, 1985: Oral aluminum administration to uremic, hyperparathyroid, or vitamin D-supplemented rats. Nephron 39: 10.
Malluche HH, Faugere MC, Friedler RM, Matthews C, Fanti P, 1987: Calcitriol parathyroid hormone, and accumulation of aluminum in bone of dogs with renal failure. J Clin Invest 79: 754.
Burnatowska-Hledin MA, Doyle TM, Eadie MJ, Mayor GH, 1986: 1, 25-dihydroxyvitamin D increases serum and tissue accumulation of aluminum in rats. J Lab Clin Med 108: 96.
Slanina P, Falkeborn Y, 1984: Aluminum concentrations in the brain and bone of rats fed citric acid, aluminum citrate or aluminum hydroxide. Fd Chem Toxic 22: 391.
Williams JW, Vera SR, Peters TG, et al., 1986: Biliary excretion of aluminum in aluminum osteodystrophy with liver disease. Ann Intern Med 104: 782.
Koning JH, 1981: (letter) N Engl J Med 304: 172.
Balasa RW, Murray RL, Kondelis NP, Bischel MD, 1987: Phosphate-binding properties and electrolyte content of aluminum hydroxide antacids. Nephron 45: 16.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Ott, S.M. (1990). Sources of aluminum. In: de Broe, M.E., Coburn, J.W. (eds) Aluminum and renal failure. Developments in Nephrology, vol 26. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1868-9_14
Download citation
DOI: https://doi.org/10.1007/978-94-009-1868-9_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7333-2
Online ISBN: 978-94-009-1868-9
eBook Packages: Springer Book Archive